Jayalakshmi Udayasankar, MD
Endocrinology · Mountain View
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 3
- 3 carriers
- Offices
- 3
Offices
3 locations · Sutter Bay Medical Foundation · 3,783 clinicians in this group
Plans that list them
3 plans · 3 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Udayasankar’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
3 of 3 plans
| Alignment Health Sutter Advantage +More (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence C142851 · Current
Licensed to practise in California · since 2016 · expires 2028-05-31 · Tamil Nadu Dr. M.G.R. Medical University, Kilpauk Medical College.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
State licence records
1 licence
- Washington MD.MD.00044777Physician And Surgeon License · since 2005 · expires 2018-05-17ExpiredNo board action on this licenceCheck it with the state
We check Colorado, Delaware, Florida, Illinois, Maryland, New Jersey, New York, Tennessee, Texas, Virginia, Washington, plus California above. A state that is not in this list has not been checked, which is not the same as clear.
Original Medicare doctor bills
$268,360
Medicare paid this office $268,360 for 279 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Injection, romosozumab-aqqg, 1 mg | 11 | $154,821 | None |
| Injection, denosumab, 1 mg | 18 | $38,150 | None |
| Return visit (30+ min) | 172 | $28,063 | $108 |
| Long return visit (40+ min) | 55 | $11,482 | $166 |
| Fine needle aspiration biopsy using ultrasound guidance, first growth | 52 | $7,317 | $131 |
See all 11 services
| Injection, romosozumab-aqqg, 1 mg | 11 | $154,821 | None |
| Injection, denosumab, 1 mg | 18 | $38,150 | None |
| Return visit (30+ min) | 172 | $28,063 | $108 |
| Long return visit (40+ min) | 55 | $11,482 | $166 |
| Fine needle aspiration biopsy using ultrasound guidance, first growth | 52 | $7,317 | $131 |
| New patient visit (45+ min) | 47 | $7,269 | $155 |
| Injection of drug or substance under skin or into muscle | 34 | $3,254 | $14 |
| Short return visit (20+ min) | 25 | $2,209 | $82 |
| Fine needle aspiration biopsy using ultrasound guidance, each additional growth | 21 | $1,575 | $56 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 86 | $1,487 | $15 |
| Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | 27 | $1,481 | $31 |
Who their Medicare patients are
279 Original Medicare patients in 2024. Average age 75 · Women 69% · Also on Medicaid 12% · Health risk score 1.09. At or below the middle of the specialty; the typical endocrinology clinician is at 1.46.
Conditions among them: High blood pressure 70% · Diabetes 42% · Chronic kidney disease 29% · Coronary heart disease 23% · Cancer 15% · Atrial fibrillation 15% · Depression 14% · Heart failure 11% · COPD 7% · Stroke 5%.
The office billed $830,374, Medicare allowed $342,661 and paid $268,360; for 22,499 services of 17 kinds; $202,603 of it was for drugs given in the office and $65,757 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 279 | 22,499 | 75 | 1.09 | $830,374 | $268,360 |
| 2023 | 298 | 8,449 | 75 | 1.07 | $466,965 | $150,930 |
| 2022 | 307 | 12,435 | 75 | 1.11 | $494,912 | $158,974 |
| 2021 | 328 | 6,560 | 75 | 1.13 | $379,531 | $124,486 |
| 2020 | 283 | 3,573 | 74 | 1.27 | $253,077 | $78,636 |
| 2019 | 297 | 1,891 | 74 | 1.27 | $250,914 | $71,875 |
| 2018 | 234 | 1,186 | 74 | 1.22 | $238,450 | $59,236 |
| 2017 | 193 | 1,124 | 73 | 1.23 | $169,855 | $45,171 |
| 2016 | 193 | 711 | 72 | 1.30 | $112,799 | $32,261 |
| 2015 | 182 | 772 | 72 | 1.19 | $123,132 | $36,369 |
| 2014 | 126 | 320 | 72 | 1.03 | $83,097 | $25,539 |
| 2013 | 216 | 610 | 70 | 1.65 | $120,243 | $36,045 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 10 services
| Injection, denosumab, 1 mg | 16 | $32,875 | None |
| Return visit (30+ min) | 177 | $32,282 | $112 |
| Long return visit (40+ min) | 56 | $11,190 | $153 |
| Fine needle aspiration biopsy using ultrasound guidance, first growth | 69 | $10,923 | $138 |
| New patient visit (45+ min) | 60 | $9,438 | $157 |
| New patient visit (60+ min) | 17 | $3,363 | $198 |
| Short return visit (20+ min) | 29 | $2,402 | $83 |
| Fine needle aspiration biopsy using ultrasound guidance, each additional growth | 26 | $1,953 | $57 |
| Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | 26 | $1,907 | $31 |
| Injection of drug or substance under skin or into muscle | 27 | $1,352 | $14 |
2022: 10 services
| Return visit (30+ min) | 165 | $27,018 | $108 |
| Injection, denosumab, 1 mg | 15 | $25,911 | None |
| Long return visit (40+ min) | 58 | $10,508 | $152 |
| New patient visit (45+ min) | 56 | $8,301 | $148 |
| Fine needle aspiration biopsy using ultrasound guidance, first growth | 57 | $8,293 | $138 |
| New patient visit (60+ min) | 22 | $4,283 | $195 |
| Short return visit (20+ min) | 40 | $3,535 | $82 |
| Fine needle aspiration biopsy using ultrasound guidance, each additional growth | 23 | $1,849 | $58 |
| Injection of drug or substance under skin or into muscle | 22 | $1,304 | $14 |
| Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | 23 | $1,253 | $31 |
2021: 10 services
| Return visit (30+ min) | 183 | $32,392 | $112 |
| Injection, denosumab, 1 mg | 16 | $25,878 | None |
| New patient visit (60+ min) | 46 | $9,176 | $199 |
| Long return visit (40+ min) | 47 | $8,898 | $165 |
| New patient visit (45+ min) | 55 | $8,627 | $157 |
| Fine needle aspiration biopsy using ultrasound guidance, first growth | 54 | $7,645 | $134 |
| Short return visit (20+ min) | 50 | $3,908 | $77 |
| Fine needle aspiration biopsy using ultrasound guidance, each additional growth | 21 | $1,632 | $58 |
| Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | 23 | $1,567 | $32 |
| Injection of drug or substance under skin or into muscle | 23 | $875 | $14 |
2020: 12 services
| Injection, denosumab, 1 mg | 14 | $24,041 | None |
| Return visit (30+ min) | 110 | $16,534 | $90 |
| New patient visit (60+ min) | 58 | $10,995 | $190 |
| Fine needle aspiration biopsy using ultrasound guidance, first growth | 56 | $7,619 | $127 |
| Short return visit (20+ min) | 86 | $6,011 | $64 |
| Telephone medical discussion with physician, 11-20 minutes | 41 | $3,929 | $73 |
| New patient visit (45+ min) | 18 | $2,445 | $136 |
| Telephone medical discussion with physician, 21-30 minutes | 19 | $2,006 | $100 |
| Long return visit (40+ min) | 12 | $1,808 | $139 |
| Fine needle aspiration biopsy using ultrasound guidance, each additional growth | 13 | $974 | $57 |
| Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | 14 | $911 | $28 |
| Injection of drug or substance under skin or into muscle | 15 | $558 | $14 |
2019: 8 services
| New patient visit (60+ min) | 103 | $18,991 | $184 |
| Return visit (30+ min) | 99 | $14,125 | $95 |
| Short return visit (20+ min) | 121 | $10,445 | $66 |
| Fine needle aspiration biopsy using ultrasound guidance, first growth | 46 | $5,961 | $124 |
| Long return visit (40+ min) | 28 | $3,668 | $126 |
| New patient visit (45+ min) | 13 | $2,024 | $156 |
| Fine needle aspiration biopsy using ultrasound guidance, each additional growth | 23 | $1,570 | $56 |
| Injection of drug or substance under skin or into muscle | 16 | $434 | $17 |
2018: 9 services
| New patient visit (60+ min) | 76 | $13,177 | $173 |
| Return visit (30+ min) | 84 | $12,002 | $87 |
| Fine needle aspiration using imaging guidance | 37 | $9,178 | $135 |
| Short return visit (20+ min) | 88 | $7,276 | $63 |
| New patient visit (45+ min) | 20 | $2,919 | $146 |
| Long return visit (40+ min) | 18 | $2,320 | $129 |
| Ultrasonic guidance for needle placement | 37 | $1,519 | $36 |
| Short return visit | 12 | $428 | $36 |
| Injection of drug or substance under skin or into muscle | 16 | $371 | $21 |
2017: 9 services
| Return visit (30+ min) | 89 | $14,852 | $88 |
| New patient visit (60+ min) | 56 | $10,317 | $184 |
| Short return visit (20+ min) | 57 | $3,995 | $61 |
| Long return visit (40+ min) | 26 | $3,328 | $119 |
| Fine needle aspiration using imaging guidance | 13 | $2,782 | $139 |
| New patient visit (45+ min) | 17 | $1,750 | $103 |
| New patient visit (30+ min) | 12 | $1,115 | $93 |
| Ultrasonic guidance for needle placement | 13 | $825 | $59 |
| Injection of drug or substance under skin or into muscle | 11 | $362 | $26 |
2016: 6 services
| Return visit (30+ min) | 89 | $10,574 | $75 |
| Short return visit (20+ min) | 71 | $5,225 | $54 |
| New patient visit (45+ min) | 35 | $4,189 | $120 |
| New patient visit (60+ min) | 25 | $3,843 | $154 |
| Long return visit (40+ min) | 19 | $2,341 | $117 |
| New patient visit (30+ min) | 13 | $997 | $77 |
2015: 4 services
| Return visit (30+ min) | 85 | $11,925 | $81 |
| New patient visit (45+ min) | 60 | $7,442 | $124 |
| Short return visit (20+ min) | 79 | $6,257 | $55 |
| New patient visit (30+ min) | 43 | $3,144 | $73 |
2014: 7 services
| Return visit (30+ min) | 50 | $8,025 | $87 |
| New patient visit (60+ min) | 34 | $5,495 | $162 |
| New patient visit (30+ min) | 42 | $3,514 | $84 |
| New patient visit (45+ min) | 20 | $2,769 | $138 |
| Short return visit (20+ min) | 36 | $2,685 | $60 |
| Long return visit (40+ min) | 13 | $1,792 | $119 |
| Blood glucose (sugar) level | 30 | $247 | $5 |
2013: 8 services
| Short return visit (20+ min) | 136 | $12,309 | $53 |
| Return visit (30+ min) | 86 | $10,058 | $80 |
| New patient visit (45+ min) | 34 | $4,282 | $126 |
| Long return visit (40+ min) | 19 | $2,530 | $120 |
| New patient visit (60+ min) | 14 | $2,070 | $148 |
| Short return visit | 38 | $1,462 | $34 |
| New patient visit (30+ min) | 16 | $1,307 | $82 |
| Blood glucose (sugar) test performed by hand-held instrument | 45 | $143 | $2 |
Medicaid work
$751 in 2023
Medicaid paid $751 for 27 billed services this clinician did in 2023, up to 15 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Return visit (30+ min) | 27 | $751 |
| 2023 | 27 | 1 | 15 | $751 |
Drugs they prescribed that Part D paid
$792,142
Pharmacies billed $792,142 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 2,039) in 2024. At or below the middle of the specialty; the typical endocrinology clinician is at 0%.
1,028 generic and 854 brand-name prescriptions · $792,142 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Ozempic | 87 | $151,869 | $1,746 |
| Jardiance | 124 | $128,350 | $1,035 |
| Mounjaro | 73 | $116,421 | $1,595 |
| Trulicity | 71 | $110,866 | $1,561 |
| Januvia | 22 | $33,390 | $1,518 |
See all 35 drugs
| Ozempic | 87 | $151,869 | $1,746 |
| Jardiance | 124 | $128,350 | $1,035 |
| Mounjaro | 73 | $116,421 | $1,595 |
| Trulicity | 71 | $110,866 | $1,561 |
| Januvia | 22 | $33,390 | $1,518 |
| Tradjenta | 13 | $18,162 | $1,397 |
| Toujeo Solostar | 16 | $14,583 | $911 |
| Tresiba Flextouch U-200 | 11 | $13,499 | $1,227 |
| Humalog Kwikpen U-100 | 34 | $13,312 | $392 |
| Basaglar Kwikpen U-100 | 21 | $10,270 | $489 |
| Lantus Solostar | 60 | $10,109 | $168 |
| Humalog Mix 75-25 Kwikpen | 13 | $8,821 | $679 |
| Nano 2nd Gen Pen Needle | 71 | $7,220 | $102 |
| Synthroid | 58 | $5,308 | $92 |
| Humalog | 13 | $5,039 | $388 |
| Humulin 70-30 | 22 | $2,968 | $135 |
| Levothyroxine | 174 | $2,045 | $12 |
| Ultra-Fine Nano Pen Needle | 15 | $1,771 | $118 |
| Atorvastatin | 142 | $1,632 | $11 |
| Metformin Hcl Er | 87 | $1,415 | $16 |
| Ultra-Fine Short Pen Needle | 13 | $1,128 | $87 |
| Metformin | 111 | $1,046 | $9 |
| Glimepiride | 100 | $1,030 | $10 |
| Glipizide Er | 45 | $1,006 | $22 |
| Rosuvastatin | 37 | $829 | $22 |
| Insulin | 17 | $732 | $43 |
| Alendronate | 84 | $729 | $9 |
| Glipizide | 68 | $620 | $9 |
| Levoxyl | 14 | $426 | $30 |
| Methimazole | 51 | $421 | $8 |
| Lisinopril | 28 | $259 | $9 |
| Losartan | 25 | $258 | $10 |
| Simvastatin | 15 | $113 | $8 |
| Amlodipine Besylate | 11 | $83 | $8 |
| Spironolactone | 11 | $56 | $5 |
Year by year
| 2024 | 2,039 | 237 | 0% (0) | 42% | $792,142 |
| 2023 | 1,992 | 235 | 0% (0) | 44% | $1,056,528 |
| 2022 | 1,969 | 247 | 0% (0) | 44% | $1,088,022 |
| 2021 | 1,884 | 237 | 0% (0) | 43% | $965,143 |
| 2020 | 1,702 | 215 | 0% (0) | 45% | $836,080 |
| 2019 | 1,515 | 206 | 0% (0) | 44% | $589,658 |
| 2018 | 1,355 | 166 | 0% (0) | 45% | $498,343 |
| 2017 | 1,054 | 201 | 0% (0) | 46% | $339,486 |
| 2016 | 1,513 | 191 | None | 42% | $358,664 |
| 2015 | 1,090 | 133 | 0% (0) | 47% | $256,377 |
| 2014 | 824 | 167 | 0% (0) | 51% | $206,552 |
| 2013 | 1,693 | 191 | None | 49% | $419,441 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 39 drugs
| Trulicity | 130 | $194,544 | $1,496 |
| Jardiance | 97 | $123,401 | $1,272 |
| Ozempic | 58 | $105,608 | $1,821 |
| Tymlos | 21 | $63,501 | $3,024 |
| Lantus Solostar | 73 | $54,765 | $750 |
| Humalog Kwikpen U-100 | 45 | $54,409 | $1,209 |
| Humalog Mix 75-25 Kwikpen | 18 | $38,394 | $2,133 |
| Mounjaro | 20 | $35,969 | $1,798 |
| Januvia | 17 | $25,285 | $1,487 |
| Humalog | 17 | $24,215 | $1,424 |
| Lantus | 20 | $23,658 | $1,183 |
| Novolog Flexpen | 20 | $21,776 | $1,089 |
| Tresiba Flextouch U-200 | 19 | $20,103 | $1,058 |
| Basaglar Kwikpen U-100 | 31 | $18,352 | $592 |
| Humulin 70-30 | 16 | $11,348 | $709 |
| Toujeo Solostar | 11 | $10,511 | $956 |
| Nano 2nd Gen Pen Needle | 60 | $6,866 | $114 |
| Synthroid | 47 | $5,650 | $120 |
| Levothyroxine | 148 | $2,791 | $19 |
| Atorvastatin | 131 | $2,320 | $18 |
| Rosuvastatin | 28 | $2,120 | $76 |
| Glimepiride | 121 | $2,093 | $17 |
| Ultra-Fine Nano Pen Needle | 22 | $1,972 | $90 |
| Glipizide | 79 | $1,872 | $24 |
| Metformin | 112 | $1,792 | $16 |
| Hydrocortisone | 18 | $1,699 | $94 |
| Glipizide Er | 45 | $1,520 | $34 |
| Ultra-Fine Short Pen Needle | 14 | $1,413 | $101 |
| Metformin Hcl Er | 69 | $1,229 | $18 |
| Alendronate | 73 | $1,149 | $16 |
| Insulin | 11 | $1,034 | $94 |
| Methimazole | 46 | $771 | $17 |
| Insulin | 13 | $709 | $55 |
| Losartan | 37 | $673 | $18 |
| Pioglitazone | 14 | $434 | $31 |
| Simvastatin | 20 | $228 | $11 |
| Levoxyl | 11 | $179 | $16 |
| Amlodipine Besylate | 15 | $137 | $9 |
| Lisinopril | 21 | $73 | $3 |
2022: 41 drugs
| Trulicity | 104 | $142,840 | $1,373 |
| Ozempic | 54 | $104,950 | $1,944 |
| Jardiance | 74 | $92,582 | $1,251 |
| Tymlos | 28 | $85,106 | $3,040 |
| Humalog Mix 75-25 Kwikpen | 18 | $55,249 | $3,069 |
| Lantus Solostar | 77 | $53,993 | $701 |
| Januvia | 35 | $52,963 | $1,513 |
| Humalog Kwikpen U-100 | 34 | $51,495 | $1,515 |
| Forteo | 11 | $46,688 | $4,244 |
| Novolog Mix 70-30 Flexpen | 22 | $38,799 | $1,764 |
| Humalog Kwikpen U-200 | 15 | $35,279 | $2,352 |
| Novolog Flexpen | 23 | $24,184 | $1,051 |
| Lantus | 18 | $23,461 | $1,303 |
| Humulin 70-30 | 16 | $22,852 | $1,428 |
| Tresiba Flextouch U-200 | 14 | $20,820 | $1,487 |
| Humalog | 14 | $18,595 | $1,328 |
| Basaglar Kwikpen U-100 | 31 | $17,368 | $560 |
| Toujeo Solostar | 14 | $16,425 | $1,173 |
| Synthroid | 51 | $4,947 | $97 |
| Nano 2nd Gen Pen Needle | 53 | $4,729 | $89 |
| Levothyroxine | 142 | $2,717 | $19 |
| Hydrocortisone | 21 | $2,400 | $114 |
| Ultra-Fine Nano Pen Needle | 30 | $2,337 | $78 |
| Glimepiride | 97 | $2,043 | $21 |
| Atorvastatin | 118 | $2,035 | $17 |
| Metformin Hcl Er | 77 | $1,819 | $24 |
| Rosuvastatin | 18 | $1,728 | $96 |
| Metformin | 116 | $1,704 | $15 |
| Glipizide Er | 29 | $1,466 | $51 |
| Glipizide | 94 | $1,437 | $15 |
| Insulin | 14 | $1,101 | $79 |
| Ultra-Fine Short Pen Needle | 12 | $1,011 | $84 |
| Insulin | 18 | $982 | $55 |
| Alendronate | 66 | $955 | $14 |
| Pioglitazone | 25 | $817 | $33 |
| Methimazole | 37 | $742 | $20 |
| Losartan | 35 | $675 | $19 |
| Simvastatin | 14 | $206 | $15 |
| Levoxyl | 11 | $205 | $19 |
| Amlodipine Besylate | 13 | $123 | $9 |
| Lisinopril | 18 | $80 | $4 |
2021: 36 drugs
| Trulicity | 115 | $169,351 | $1,473 |
| Forteo | 15 | $74,192 | $4,946 |
| Humalog Kwikpen U-100 | 39 | $65,232 | $1,673 |
| Jardiance | 47 | $61,397 | $1,306 |
| Humalog Mix 75-25 Kwikpen | 20 | $60,656 | $3,033 |
| Lantus Solostar | 102 | $58,905 | $577 |
| Ozempic | 33 | $51,430 | $1,558 |
| Januvia | 39 | $50,210 | $1,287 |
| Novolog Mix 70-30 Flexpen | 21 | $38,622 | $1,839 |
| Novolog Flexpen | 24 | $27,488 | $1,145 |
| Lantus | 19 | $23,489 | $1,236 |
| Humulin 70-30 | 19 | $18,919 | $996 |
| Humalog | 14 | $15,486 | $1,106 |
| Basaglar Kwikpen U-100 | 27 | $14,269 | $528 |
| Toujeo Solostar | 12 | $8,423 | $702 |
| Levemir Flextouch | 13 | $6,075 | $467 |
| Synthroid | 51 | $4,845 | $95 |
| Nano 2nd Gen Pen Needle | 50 | $4,169 | $83 |
| Levothyroxine | 132 | $3,038 | $23 |
| Hydrocortisone | 21 | $2,892 | $138 |
| Ultra-Fine Nano Pen Needle | 26 | $2,146 | $83 |
| Metformin Hcl Er | 82 | $1,992 | $24 |
| Glimepiride | 94 | $1,774 | $19 |
| Atorvastatin | 114 | $1,764 | $15 |
| Metformin | 121 | $1,486 | $12 |
| Insulin | 19 | $1,238 | $65 |
| Alendronate | 70 | $1,059 | $15 |
| Glipizide Er | 27 | $1,032 | $38 |
| Glipizide | 85 | $987 | $12 |
| Pioglitazone | 24 | $787 | $33 |
| Levoxyl | 14 | $645 | $46 |
| Losartan | 33 | $635 | $19 |
| Methimazole | 27 | $471 | $17 |
| Lisinopril | 19 | $145 | $8 |
| Simvastatin | 15 | $97 | $6 |
| Amlodipine Besylate | 11 | $58 | $5 |
2020: 39 drugs
| Forteo | 22 | $153,706 | $6,987 |
| Trulicity | 82 | $101,173 | $1,234 |
| Jardiance | 58 | $64,892 | $1,119 |
| Humalog Mix 75-25 Kwikpen | 38 | $59,949 | $1,578 |
| Lantus Solostar | 81 | $48,559 | $599 |
| Humalog Kwikpen U-100 | 30 | $40,483 | $1,349 |
| Januvia | 34 | $38,491 | $1,132 |
| Ozempic | 15 | $32,752 | $2,183 |
| Novolog Flexpen | 26 | $29,777 | $1,145 |
| Novolog Mix 70-30 Flexpen | 14 | $25,831 | $1,845 |
| Lantus | 15 | $21,205 | $1,414 |
| Humulin 70-30 | 18 | $12,837 | $713 |
| Victoza 2-Pak | 11 | $12,723 | $1,157 |
| Toujeo Solostar | 12 | $12,195 | $1,016 |
| Humalog | 15 | $11,934 | $796 |
| Basaglar Kwikpen U-100 | 24 | $10,832 | $451 |
| Tradjenta | 11 | $7,397 | $672 |
| Synthroid | 47 | $4,460 | $95 |
| Levothyroxine | 124 | $3,607 | $29 |
| Ultra-Fine Nano Pen Needle | 46 | $3,428 | $75 |
| Glimepiride | 105 | $1,518 | $14 |
| Atorvastatin | 106 | $1,513 | $14 |
| Ultra-Fine Short Pen Needle | 11 | $1,412 | $128 |
| Metformin Hcl Er | 56 | $1,298 | $23 |
| Hydrocortisone | 20 | $1,271 | $64 |
| Glipizide Er | 30 | $1,161 | $39 |
| Nano 2nd Gen Pen Needle | 16 | $1,110 | $69 |
| Metformin | 89 | $1,030 | $12 |
| Alendronate | 64 | $950 | $15 |
| Methimazole | 24 | $934 | $39 |
| Glipizide | 77 | $900 | $12 |
| Pioglitazone | 19 | $775 | $41 |
| Levoxyl | 17 | $640 | $38 |
| Insulin | 12 | $590 | $49 |
| Losartan | 31 | $497 | $16 |
| Calcitriol | 13 | $305 | $23 |
| Lisinopril | 17 | $194 | $11 |
| Simvastatin | 15 | $126 | $8 |
| Amlodipine Besylate | 11 | $45 | $4 |
2019: 37 drugs
| Forteo | 15 | $82,186 | $5,479 |
| Trulicity | 60 | $58,390 | $973 |
| Jardiance | 47 | $44,046 | $937 |
| Januvia | 46 | $39,943 | $868 |
| Humalog Mix 75-25 Kwikpen | 25 | $36,570 | $1,463 |
| Lantus Solostar | 63 | $35,851 | $569 |
| Toujeo Solostar | 27 | $26,138 | $968 |
| Novolog Mix 70-30 Flexpen | 11 | $21,578 | $1,962 |
| Humalog Kwikpen U-100 | 20 | $18,697 | $935 |
| Lantus | 17 | $18,598 | $1,094 |
| Invokana | 17 | $16,966 | $998 |
| Androderm | 11 | $10,392 | $945 |
| Tradjenta | 15 | $9,865 | $658 |
| Humulin 70-30 | 18 | $9,496 | $528 |
| Humalog | 14 | $9,475 | $677 |
| Novolog Flexpen | 12 | $8,800 | $733 |
| Humulin R | 12 | $6,801 | $567 |
| Synthroid | 61 | $5,409 | $89 |
| Ultra-Fine Nano Pen Needle | 45 | $2,677 | $59 |
| Levothyroxine | 82 | $2,299 | $28 |
| Glipizide Er | 38 | $1,909 | $50 |
| Atorvastatin | 74 | $1,409 | $19 |
| Glimepiride | 100 | $1,302 | $13 |
| Metformin | 92 | $1,162 | $13 |
| Liothyronine | 14 | $1,029 | $73 |
| Metformin Hcl Er | 59 | $913 | $15 |
| Insulin | 21 | $910 | $43 |
| Glipizide | 82 | $909 | $11 |
| Pioglitazone | 15 | $659 | $44 |
| Hydrocortisone | 11 | $573 | $52 |
| Levoxyl | 16 | $558 | $35 |
| Alendronate | 35 | $488 | $14 |
| Methimazole | 26 | $326 | $13 |
| Losartan | 21 | $321 | $15 |
| Calcitriol | 13 | $295 | $23 |
| Lisinopril | 20 | $173 | $9 |
| Simvastatin | 13 | $152 | $12 |
2018: 31 drugs
| Forteo | 25 | $88,302 | $3,532 |
| Humalog Mix 75-25 Kwikpen | 23 | $33,454 | $1,455 |
| Januvia | 48 | $32,862 | $685 |
| Lantus Solostar | 60 | $30,666 | $511 |
| Jardiance | 42 | $29,844 | $711 |
| Trulicity | 32 | $28,780 | $899 |
| Invokana | 37 | $28,398 | $768 |
| Lantus | 33 | $21,371 | $648 |
| Novolog Mix 70-30 Flexpen | 15 | $17,924 | $1,195 |
| Novolog | 11 | $16,493 | $1,499 |
| Humulin 70-30 | 23 | $10,086 | $439 |
| Humulin R | 14 | $7,627 | $545 |
| Metformin Er Osmotic | 13 | $6,550 | $504 |
| Synthroid | 72 | $4,781 | $66 |
| Ultra-Fine Nano Pen Needle | 44 | $2,802 | $64 |
| Rosuvastatin | 11 | $1,735 | $158 |
| Levothyroxine | 74 | $1,618 | $22 |
| Glimepiride | 80 | $1,410 | $18 |
| Glipizide Er | 24 | $1,284 | $53 |
| Metformin | 75 | $1,062 | $14 |
| Atorvastatin | 54 | $961 | $18 |
| Metformin Hcl Er | 89 | $953 | $11 |
| Ultra-Fine Mini Pen Needle | 11 | $886 | $81 |
| Levoxyl | 17 | $614 | $36 |
| Glipizide | 60 | $588 | $10 |
| Liothyronine | 12 | $514 | $43 |
| Insulin | 15 | $501 | $33 |
| Methimazole | 23 | $260 | $11 |
| Alendronate | 18 | $182 | $10 |
| Lisinopril | 23 | $168 | $7 |
| Gabapentin | 18 | $138 | $8 |
2017: 30 drugs
| Forteo | 19 | $58,766 | $3,093 |
| Lantus Solostar | 54 | $29,624 | $549 |
| Lantus | 45 | $21,729 | $483 |
| Novolog | 11 | $19,110 | $1,737 |
| Novolog Flexpen | 19 | $18,339 | $965 |
| Trulicity | 27 | $18,106 | $671 |
| Invokana | 25 | $17,859 | $714 |
| Januvia | 25 | $16,960 | $678 |
| Humalog Mix 75-25 Kwikpen | 16 | $15,810 | $988 |
| Victoza 3-Pak | 11 | $8,468 | $770 |
| Jardiance | 16 | $8,156 | $510 |
| Humalog Kwikpen U-100 | 11 | $6,359 | $578 |
| Levemir Flextouch | 14 | $5,694 | $407 |
| Humulin R | 14 | $5,656 | $404 |
| Metformin Hcl Er | 42 | $3,532 | $84 |
| Novolin N | 11 | $3,432 | $312 |
| Ultra-Fine Nano Pen Needle | 37 | $2,294 | $62 |
| Synthroid | 32 | $2,281 | $71 |
| Levothyroxine | 88 | $1,768 | $20 |
| Metformin | 73 | $769 | $11 |
| Insulin | 21 | $727 | $35 |
| Glimepiride | 32 | $712 | $22 |
| Liothyronine | 13 | $618 | $48 |
| Atorvastatin | 29 | $528 | $18 |
| Glipizide | 57 | $434 | $8 |
| Methimazole | 25 | $282 | $11 |
| Pravastatin | 12 | $170 | $14 |
| Alendronate | 12 | $102 | $8 |
| Gabapentin | 12 | $87 | $7 |
| Lisinopril | 16 | $73 | $5 |
2016: 36 drugs
| Lantus Solostar | 143 | $69,831 | $488 |
| Humalog Kwikpen U-100 | 74 | $48,641 | $657 |
| Novolog Flexpen | 29 | $18,449 | $636 |
| Victoza 2-Pak | 19 | $17,801 | $937 |
| Lantus | 47 | $17,600 | $374 |
| Levemir Flextouch | 26 | $16,038 | $617 |
| Januvia | 20 | $8,904 | $445 |
| Novolog Mix 70-30 Flexpen | 12 | $8,134 | $678 |
| Bd Ultra-Fine Pen Needle | 95 | $7,236 | $76 |
| Tradjenta | 14 | $7,048 | $503 |
| Humalog | 12 | $5,990 | $499 |
| Levothyroxine | 183 | $3,938 | $22 |
| Novolog | 12 | $2,987 | $249 |
| Calcitriol | 22 | $1,024 | $47 |
| Synthroid | 24 | $925 | $39 |
| Glimepiride | 38 | $870 | $23 |
| Atorvastatin | 57 | $856 | $15 |
| Novofine Autocover | 16 | $851 | $53 |
| Hydrocortisone | 15 | $631 | $42 |
| Metformin | 82 | $609 | $7 |
| Pravastatin | 21 | $566 | $27 |
| Glipizide | 102 | $547 | $5 |
| Novofine 32 | 12 | $533 | $44 |
| Gabapentin | 13 | $520 | $40 |
| Liothyronine | 17 | $398 | $23 |
| Metformin Hcl Er | 45 | $393 | $9 |
| Insulin | 16 | $340 | $21 |
| Testosterone Cypionate | 14 | $231 | $17 |
| Methimazole | 23 | $223 | $10 |
| Losartan | 26 | $215 | $8 |
| Fludrocortisone Acetate | 12 | $146 | $12 |
| Prednisone | 16 | $134 | $8 |
| Lisinopril | 27 | $122 | $5 |
| Amlodipine Besylate | 21 | $88 | $4 |
| Losartan-Hydrochlorothiazide | 11 | $86 | $8 |
| Hydrochlorothiazide | 13 | $73 | $6 |
2015: 24 drugs
| Lantus Solostar | 109 | $54,291 | $498 |
| Humalog Kwikpen U-100 | 40 | $29,457 | $736 |
| Lantus | 46 | $24,248 | $527 |
| Forteo | 12 | $23,092 | $1,924 |
| Novolog Flexpen | 32 | $16,769 | $524 |
| Levemir Flextouch | 16 | $14,352 | $897 |
| Victoza 2-Pak | 13 | $7,867 | $605 |
| Januvia | 14 | $7,310 | $522 |
| Novolog | 15 | $4,365 | $291 |
| Novolin 70-30 | 18 | $4,185 | $233 |
| Bd Ultra-Fine Pen Needle | 53 | $4,170 | $79 |
| Levothyroxine | 108 | $2,183 | $20 |
| Synthroid | 29 | $957 | $33 |
| Novofine Autocover | 13 | $846 | $65 |
| Atorvastatin | 42 | $680 | $16 |
| Pravastatin | 29 | $670 | $23 |
| Glipizide | 86 | $568 | $7 |
| Insulin | 21 | $402 | $19 |
| Novofine 32 | 13 | $375 | $29 |
| Metformin | 58 | $372 | $6 |
| Metformin Hcl Er | 34 | $350 | $10 |
| Glimepiride | 23 | $335 | $15 |
| Losartan | 24 | $170 | $7 |
| Methimazole | 12 | $88 | $7 |
2014: 18 drugs
| Lantus Solostar | 66 | $26,921 | $408 |
| Humulin R | 21 | $25,131 | $1,197 |
| Lantus | 48 | $24,450 | $509 |
| Novolog Flexpen | 55 | $23,595 | $429 |
| Humalog | 35 | $19,283 | $551 |
| Januvia | 18 | $7,271 | $404 |
| Bd Ultra-Fine Pen Needle | 67 | $4,844 | $72 |
| Novolog | 13 | $4,205 | $323 |
| Levothyroxine | 89 | $1,426 | $16 |
| Insulin | 26 | $771 | $30 |
| Atorvastatin | 20 | $588 | $29 |
| Metformin | 45 | $441 | $10 |
| Pravastatin | 18 | $391 | $22 |
| Synthroid | 14 | $337 | $24 |
| Glipizide | 50 | $329 | $7 |
| Losartan | 17 | $285 | $17 |
| Glimepiride | 11 | $285 | $26 |
| Lisinopril | 14 | $108 | $8 |
2013: 39 drugs
| Humulin R | 78 | $74,837 | $959 |
| Humalog | 75 | $39,947 | $533 |
| Lantus Solostar | 103 | $38,994 | $379 |
| Forteo | 25 | $33,186 | $1,327 |
| Lantus | 94 | $32,921 | $350 |
| Novolog Mix 70-30 Flexpen | 26 | $32,788 | $1,261 |
| Novolog Flexpen | 57 | $22,105 | $388 |
| Januvia | 52 | $21,010 | $404 |
| Symlinpen 120 | 14 | $14,662 | $1,047 |
| Levemir Flexpen | 18 | $14,399 | $800 |
| Humalog Mix 75-25 | 15 | $14,041 | $936 |
| Novolog | 37 | $12,406 | $335 |
| Bd Ultra-Fine Pen Needle | 139 | $7,913 | $57 |
| Glucagon Emergency Kit | 14 | $4,585 | $327 |
| Lovaza | 15 | $4,424 | $295 |
| Novolin 70-30 | 15 | $3,344 | $223 |
| Fenofibrate | 14 | $2,793 | $199 |
| Insulin | 60 | $2,363 | $39 |
| Humulin N | 11 | $2,071 | $188 |
| Atorvastatin | 44 | $2,046 | $46 |
| Levothyroxine | 133 | $1,442 | $11 |
| Metformin | 104 | $1,309 | $13 |
| Testosterone Cypionate | 21 | $1,273 | $61 |
| Novolin N | 17 | $1,192 | $70 |
| Calcitriol | 15 | $991 | $66 |
| Insulin | 21 | $615 | $29 |
| Glipizide | 41 | $474 | $12 |
| Insulin | 19 | $448 | $24 |
| Simvastatin | 30 | $405 | $14 |
| Felodipine Er | 11 | $354 | $32 |
| Lisinopril | 43 | $342 | $8 |
| Synthroid | 15 | $312 | $21 |
| Amlodipine Besylate | 28 | $306 | $11 |
| Lovastatin | 20 | $262 | $13 |
| Hydrochlorothiazide | 31 | $248 | $8 |
| Pravastatin | 11 | $204 | $19 |
| Glimepiride | 11 | $108 | $10 |
| Alendronate | 11 | $93 | $8 |
| Prednisone | 14 | $80 | $6 |
Money from drug and device companies
$163 in 2025
| 2025 | 3 | 3 | None | $163 |
| 2024 | 1 | 1 | None | $50 |
| 2022 | 1 | 1 | None | $12 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Ascendis Pharma Endocrinology | Yorvipath | $122 | 1 payment
|
| Neurocrine BioSciences | Crenessity | $24 | 1 payment
|
| Abbott Laboratories | Freestyle Libre 3 | $17 | 1 payment
|
See all 3 published payments
| Ascendis Pharma Endocrinology | Meals · 2025-04-05 | Yorvipath | $122 |
| Neurocrine BioSciences | Education · 2025-03-21 | Crenessity | $24 |
| Abbott Laboratories | Meals · 2025-02-07 | Freestyle Libre 3 | $17 |
See earlier years (2024, 2022)
2024: $50
| Radius Health | Tymlos | $50 | 1 payment
|
2022: $12
| Lilly USA | None | $12 | 1 payment
|
Professional record
- NPI
- 1689785545
- Licence
- CA C142851, WA MD00044777California C142851: Current · expires 2028-05-31Washington MD.MD.00044777: Expired
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207RE0101X (207RE0101X)
- Mailing address
- 2350 W. El Camino Real, 2nd Floor, Mountain View, CA, 94040
- NPI first listed
- 2006-08-31
- NPI last updated
- 2016-11-08
This is when the NPI record was last certified, not a medical board exam.